Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.5% | 16.1% | 34.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.8% | 67% | 68.7% | 71.5% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 3.1% | 12.6% | -3.6% | -243.4% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 1.4% | 3.5% | -8.8% | -252.7% |
| EPS Diluted | 0.013 | 0.072 | -0.1 | -4.3 |
| % Growth | -81.3% | 171.5% | 97.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |